1 |
Del Papa N, Minniti A, Maglione W, Pignataro F, Caporali R, Vitali C. Instruments for Outcome Evaluation of Specific Domains in Primary Sjögren's Syndrome. Biomolecules 2021;11:953. [PMID: 34203480 DOI: 10.3390/biom11070953] [Reference Citation Analysis]
|
2 |
Chatzis LG, Stergiou IE, Goules AV, Pezoulas V, Tsourouflis G, Fotiadis D, Tzioufas AG, Voulgarelis M. Clinical picture, outcome, and predictive factors of lymphoma in primary Sjogren's syndrome. Results from a harmonized dataset (1981-2021). Rheumatology (Oxford) 2021:keab939. [PMID: 34940812 DOI: 10.1093/rheumatology/keab939] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
3 |
Vitali C, Minniti A, Pignataro F, Maglione W, Del Papa N. Management of Sjögren's Syndrome: Present Issues and Future Perspectives. Front Med (Lausanne) 2021;8:676885. [PMID: 34164418 DOI: 10.3389/fmed.2021.676885] [Reference Citation Analysis]
|
4 |
Chang CM, Wu PC, Lin JR, Jan Wu YJ, Luo SF, Hsue YT, Lan JL, Pan TL, Wu YT, Yu KH, Wei YH, Chang HH. Herbal Formula SS-1 Increases Tear Secretion for Sjögren's Syndrome. Front Pharmacol 2021;12:645437. [PMID: 34630072 DOI: 10.3389/fphar.2021.645437] [Reference Citation Analysis]
|